Call Options Transactions Made in Q2 2023 in Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO) during Q2 2023. The information is specifically focused on institutions that hold call options of HALOZYME THERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
CALL |
98KNew |
$2.97M - $3.8M
|
98K
$5.17M
|
|
|
Aug 14, 2023
Q2 2023
|
Capital Fund Management S.A.
Paris, I0 |
BUY
|
CALL |
52.5KNew |
$1.59M - $2.03M
|
52.5K
$2.77M
|
|
|
Aug 14, 2023
Q2 2023
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
CALL |
30KNew |
$908K - $1.16M
|
30K
$1.58M
|
|
|
Aug 14, 2023
Q2 2023
|
Cubist Systematic Strategies, LLC
Stamford, CT |
BUY
|
CALL |
19.7KNew |
$597K - $763K
|
19.7K
$1.04M
|
|
|
Aug 14, 2023
Q2 2023
|
Centiva Capital, LP
New York, NY |
BUY
|
CALL |
11.7KNew |
$354K - $453K
|
11.7K
$618K
|
|
|
Aug 14, 2023
Q2 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
6K+ 24.0% |
$182K - $232K
|
31K
$1.64M
|
|
|
Aug 11, 2023
Q2 2023
|
Peak6 Investments LLC
Chicago, IL |
SELL
|
CALL |
-5.2K- 28.57% |
$157K - $201K
|
13K
$686K
|
|
|
Aug 11, 2023
Q2 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-32.9K- 19.53% |
$996K - $1.27M
|
136K
$7.16M
|